QQ客服 官方微博 反馈留言

	EFFICACY AND SAFETY OF BARICITINIB IN MTX-IR PATIENTS WITH RHEUMATOID ARTHRITIS: 52 WEEK RESULTS FROM A PHASE 3 STUDY (RA-BALANCE)
	Li, Z.; Hu, J.; Bao, C.; Li, X.; Li, X.; Xu, J.; Spindler, A.; Zhang, X.; Xu, J.; Li, Z.
刊名	ANNALS OF THE RHEUMATIC DISEASES
	2018
卷号	77
ISSN号	0003-4967
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3415902
专题	昆明医科大学
推荐引用方式 GB/T 7714	Li, Z.,Hu, J.,Bao, C.,et al. EFFICACY AND SAFETY OF BARICITINIB IN MTX-IR PATIENTS WITH RHEUMATOID ARTHRITIS: 52 WEEK RESULTS FROM A PHASE 3 STUDY (RA-BALANCE)[J]. ANNALS OF THE RHEUMATIC DISEASES,2018,77.
APA	Li, Z..,Hu, J..,Bao, C..,Li, X..,Li, X..,...&Zerbini, C..(2018).EFFICACY AND SAFETY OF BARICITINIB IN MTX-IR PATIENTS WITH RHEUMATOID ARTHRITIS: 52 WEEK RESULTS FROM A PHASE 3 STUDY (RA-BALANCE).ANNALS OF THE RHEUMATIC DISEASES,77.
MLA	Li, Z.,et al."EFFICACY AND SAFETY OF BARICITINIB IN MTX-IR PATIENTS WITH RHEUMATOID ARTHRITIS: 52 WEEK RESULTS FROM A PHASE 3 STUDY (RA-BALANCE)".ANNALS OF THE RHEUMATIC DISEASES 77(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。